PMC Articles for MedGen (Select 235127) - PMC

Dong Yang, Pian Li, Zhen Meng, Xueying Hu, Zichong Huang, Heqing Huang, Huan Dong, Yating Qin, Cong Chen, Xinghua Chen, Zhiru Li, Ziyan Zhou, Yi Li, Min Kang

Sci Rep. 2024; 14: 9898. Published online 2024 Apr 30. doi: 10.1038/s41598-024-59131-2

PMCID:: PMC11061272

Abstract Article PDF–1.6M

Select item 109920084.

Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma

Chwee Ming Lim, Anthony Liou, Michelle Poon, Liang Piu Koh, Lip Kun Tan, Kwok Seng Loh, Bengt Fredrik Petersson, Eric Ting, Dario Campana, Boon Cher Goh, Noriko Shimasaki

Cancer Immunol Immunother. 2022 Sep; 71(9): 2277–2286. Published online 2022 Jan 30. doi: 10.1007/s00262-022-03158-9

PMCID:: PMC10992008

Abstract Article PDF–739K

Select item 109913645.

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit

Emily Nickles, Bhushan Dharmadhikari, Li Yating, Robert J. Walsh, Liang Piu Koh, Michelle Poon, Lip Kun Tan, Ling-Zhi Wang, Yvonne Ang, Yugarajah Asokumaran, Wan Qin Chong, Yiqing Huang, Kwok Seng Loh, Joshua Tay, Ross Soo, Mickey Koh, Liam Pock Ho, Marieta Chan, Madelaine Niam, Melissa Soh, Yen Hoon Luah, Chwee Ming Lim, Nivashini Kaliaperumal, Veonice B. Au, Najwa Binte Said Nasir Talib, Reina Sng, John E. Connolly, Boon Cher Goh, Herbert Schwarz

Cancer Immunol Immunother. 2022 Jun; 71(6): 1531–1543. Published online 2021 Oct 18. doi: 10.1007/s00262-021-03075-3

PMCID:: PMC10991364

Abstract Article PDF–906K

Select item 108733106.

Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy

Yuebing Chen, Chuying Chen, Hewei Peng, Shaojun Lin, Jianji Pan, Huiping Zheng, Jingfeng Zong, Cheng Lin

Sci Rep. 2024; 14: 3950. Published online 2024 Feb 17. doi: 10.1038/s41598-024-54230-6

PMCID:: PMC10873310

Abstract Article PDF–1.6M

Select item 108076837.

Long‐term outcomes of metastasis‐directed stereotactic body radiation therapy in metastatic nasopharyngeal carcinoma

Jiangping Yang, Wenjun Liao, Shitong Su, Ni Zeng, Shichuan Zhang, Jinlan He, Nianyong Chen

Cancer Med. 2024 Jan; 13(1): e6764. Published online 2023 Dec 26. doi: 10.1002/cam4.6764

PMCID:: PMC10807683

Abstract Article PDF–1.9M

Select item 107989528.

Combination strategy exploration for prior treated recurrent or metastatic nasopharyngeal carcinoma in the era of immunotherapy

Yaofei Jiang, Chun Chen, Guoying Liu, Ting Fang, Nian Lu, Weixin Bei, Shuhui Dong, Wangzhong Li, Weixiong Xia, Hu Liang, Yanqun Xiang

Sci Rep. 2024; 14: 1768. Published online 2024 Jan 20. doi: 10.1038/s41598-024-52326-7

PMCID:: PMC10798952

Abstract Article PDF–1.0M

Select item 107951629.

Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study

Yunyan Mo, Yufei Pan, Bin Zhang, Jian Zhang, Yixin Su, Zhengchun Liu, Meiqing Luo, Guanjie Qin, Xiangyun Kong, Rongjun Zhang, Yu Pan, Yi Liang, Defeng Wang, Yuejia Wei, Hengwei Chen, Wei Jiang

Front Immunol. 2023; 14: 1298418. Published online 2024 Jan 3. doi: 10.3389/fimmu.2023.1298418

PMCID:: PMC10795162

Abstract Article PDF–1.3M

Select item 1075712910.

Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma

Tian‐Zhu Lu, Fu‐juan Zeng, Yu‐Jun Hu, Min Fang, Fang‐yan Zhong, Bi‐juan Chen, Hao Zhang, Qiao‐juan Guo, Jian‐ji Pan, Xiao‐chang Gong, Shao Hui Huang, Zhao‐hui Liao, Yunfei Xia, Jin‐gao Li

Cancer Med. 2023 Dec; 12(24): 22091–22102. Published online 2023 Dec 11. doi: 10.1002/cam4.6816

PMCID:: PMC10757129

Abstract Article PDF–2.3M

Select item 1074899011.

Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in China

Ziying Zhao, Tongfeng Chen, Zhen Zhou, Rui Guo, Qiao Liu

BMJ Open. 2023; 13(12): e071832. Published online 2023 Dec 18. doi: 10.1136/bmjopen-2023-071832

PMCID:: PMC10748990

Abstract Article PDF–628K

Select item 1069466112.

Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial

Si-Yuan Chen, Xiao-Tong Duan, Hui-Feng Li, Lan Peng, Zhi-Qiang Wang, Gui-Qiong Xu, Yi-Jun Hua, Xiong Zou, Rui You, Yan-Feng Ouyang, You-Ping Liu, Chen-Mei Gu, Qi Yang, Rou Jiang, Meng-Xia Zhang, Mei Lin, Yu-Long Xie, Chao Lin, Xi Ding, Ruo-Qi Xie, Chong-Yang Duan, Wei-Jing Zhang, Pei-Yu Huang, Ming-Yuan Chen

Cell Rep Med. 2023 Nov 21; 4(11): 101279. Published online 2023 Nov 10. doi: 10.1016/j.xcrm.2023.101279

PMCID:: PMC10694661

Abstract Article PDF–2.9M

Select item 1068805613.

Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis

Jian Luo, Wanying Xiao, Fengyang Hua, Yanqing Cao, Dongxia Wang, Xicheng Wang

BMC Cancer. 2023; 23: 1172. Published online 2023 Nov 30. doi: 10.1186/s12885-023-11318-y

PMCID:: PMC10688056

Abstract Article PDF–2.2M

Select item 1068588214.

Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial

Hai-Qiang Mai, Qiu-Yan Chen, Dongping Chen, Chaosu Hu, Kunyu Yang, Jiyu Wen, Jingao Li, Yingrui Shi, Feng Jin, Ruilian Xu, Jianji Pan, Shenhong Qu, Ping Li, Chunhong Hu, Yi-Chun Liu, Yi Jiang, Xia He, Hung-Ming Wang, Wan-Teck Lim, Wangjun Liao, Xiaohui He, Xiaozhong Chen, Siyang Wang, Xianglin Yuan, Qi Li, Xiaoyan Lin, Shanghua Jing, Yanju Chen, Yin Lu, Ching-Yun Hsieh, Muh-Hwa Yang, Chia-Jui Yen, Jens Samol, Xianming Luo, Xiaojun Wang, Xiongwen Tang, Hui Feng, Sheng Yao, Patricia Keegan, Rui-Hua Xu

JAMA. 2023 Nov 28; 330(20): 1961–1970. Published online 2023 Nov 28. doi: 10.1001/jama.2023.20181